Pfizer's 2015 forecast disappoints, crimped by generics, dollar

(Reuters) - Pfizer Inc reported stronger-than-expected quarterly results as sales of vaccines and cancer drugs increased, but the company forecast 2015 earnings below Wall Street expectations, citing patent expirations and the stronger dollar.